Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor plus G-CSF vs placebo plus G-CSF for stem cell mobilization in NHL
CTR20132583Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plerixafor in non-Hodgkin lymphoma (NHL), sponsored by Sanofi. Started Jul 2014; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on CTR20132583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132583.